AgeX Therapeutics, Inc. SEC Filings https://investors.agexinc.com/generated by Q4Fri, 27 Mar 2026 13:57:59 -0400Copyright Q4 Inc. All rights reserved.AgeX Therapeutics, Inc. - 10-K/A - Amended Annual Report19292939https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19292939Fri, 27 Mar 2026 00:00:00 -0400AgeX Therapeutics, Inc. - S-8 - Securities Registration: Employee Benefit Plan19283894https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19283894Wed, 25 Mar 2026 00:00:00 -0400AgeX Therapeutics, Inc. - 8-K - Current report filing19282870https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19282870Wed, 25 Mar 2026 00:00:00 -0400AgeX Therapeutics, Inc. - 10-K - Annual Report19282791https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19282791Wed, 25 Mar 2026 00:00:00 -0400AgeX Therapeutics, Inc. - 4 - Statement of Changes in Beneficial Ownership19280103https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19280103Tue, 24 Mar 2026 00:00:00 -0400AgeX Therapeutics, Inc. - 8-K - Current report filing19275468https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19275468Mon, 23 Mar 2026 00:00:00 -0400AgeX Therapeutics, Inc. - 4 - Statement of Changes in Beneficial Ownership19271767https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19271767Fri, 20 Mar 2026 00:00:00 -0400AgeX Therapeutics, Inc. - 4 - Statement of Changes in Beneficial Ownership19151111https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19151111Tue, 17 Feb 2026 00:00:00 -0500AgeX Therapeutics, Inc. - 4 - Statement of Changes in Beneficial Ownership19151045https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19151045Tue, 17 Feb 2026 00:00:00 -0500AgeX Therapeutics, Inc. - 4 - Statement of Changes in Beneficial Ownership19151023https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19151023Tue, 17 Feb 2026 00:00:00 -0500AgeX Therapeutics, Inc. - 4 - Statement of Changes in Beneficial Ownership19151003https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19151003Tue, 17 Feb 2026 00:00:00 -0500AgeX Therapeutics, Inc. - EFFECT - Effectiveness Order19150359https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19150359Fri, 13 Feb 2026 00:00:00 -0500AgeX Therapeutics, Inc. - 4 - Statement of Changes in Beneficial Ownership19110451https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19110451Tue, 03 Feb 2026 00:00:00 -0500AgeX Therapeutics, Inc. - S-3 - Securities Registration Statement (simplified form)19104167https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19104167Fri, 30 Jan 2026 00:00:00 -0500AgeX Therapeutics, Inc. - 4 - Statement of Changes in Beneficial Ownership19096840https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19096840Thu, 29 Jan 2026 00:00:00 -0500AgeX Therapeutics, Inc. - 8-K - Current report filing19093583https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19093583Wed, 28 Jan 2026 00:00:00 -0500AgeX Therapeutics, Inc. - 4 - Statement of Changes in Beneficial Ownership19080280https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19080280Fri, 23 Jan 2026 00:00:00 -0500AgeX Therapeutics, Inc. - 4 - Statement of Changes in Beneficial Ownership19075802https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19075802Wed, 21 Jan 2026 00:00:00 -0500AgeX Therapeutics, Inc. - 144 - Report of proposed sale of securities19070671https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19070671Tue, 20 Jan 2026 00:00:00 -0500AgeX Therapeutics, Inc. - 8-K - Current report filing19064738https://investors.agexinc.com/financial-information/sec-filings/sec-filings-details/default.aspx?FilingId=19064738Thu, 15 Jan 2026 00:00:00 -0500